Citadel Advisors’s iShares Evolved U.S. Healthcare Staples ETF IEHS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-19,324
Closed -$742K 14218
2022
Q2
$742K Buy
+19,324
New +$782K ﹤0.01% 7723
2021
Q3
Sell
-35,429
Closed -$1.47M 15126
2021
Q2
$1.47M Buy
+35,429
New +$1.44M ﹤0.01% 7356
2020
Q1
Sell
-24,665
Closed -$789K 10426
2019
Q4
$789K Sell
24,665
-3,907
-14% -$118K ﹤0.01% 6027
2019
Q3
$817K Buy
28,572
+241
+0.9% +$7.04K ﹤0.01% 5943
2019
Q2
$826K Buy
+28,331
New +$788K ﹤0.01% 6014

Other funds holding IEHS

Citadel Advisors's IEHS Position: Q3 2022 in Review

Citadel Advisors sold out of iShares Evolved U.S. Healthcare Staples ETF (IEHS) in Q3 2022, closing a stake of 19,324 shares — an estimated $742K sold.

Citadel Advisors first reported a position in IEHS in Q2 2019 and held it in 5 quarters. The position peaked at $1.47M in Q2 2021. 2 funds tracked by Wall St. Rank hold IEHS as of Q3 2022.

  • Citadel Advisors reported no remaining iShares Evolved U.S. Healthcare Staples ETF position as of Q3 2022 after selling out during the quarter.
  • Citadel Advisors sold 19,324 iShares Evolved U.S. Healthcare Staples ETF shares in Q3 2022, an estimated $742K.
  • Citadel Advisors first reported a position in iShares Evolved U.S. Healthcare Staples ETF in Q2 2019 and held it in 5 quarters.
  • Citadel Advisors's iShares Evolved U.S. Healthcare Staples ETF position peaked at $1.47M in Q2 2021.
  • 2 funds tracked by Wall St. Rank held iShares Evolved U.S. Healthcare Staples ETF as of Q3 2022.

Based on Citadel Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.